Updated June 23 2017 |
Online Partnership to Accelerate Research (OnPAR) Leidos has worked with NIH Program Officers to inform applicant Principal Investigators that have scored well, but below the Institue/Center payline, about OnPAR. If an applicant scored in the top 30% and is not funded by NIH, he/she is welcome to submit an abstract for consideration. Qualified applicants are invited to register with OnPAR and participate in the submission and review process described below. It is not necessary to re-write an application. OnPAR will accept the NIH abstract that was submitted by the applicant, and if invited, his/her submitted NIH application and Summary Statement. For more information, click here. |
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24) (PAR-15-266) National Cancer Institute Application Receipt/Submission Dates: November 17, 2017, June 14, 2018, by 5:00 PM local time of applicant organization. |
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) (PAR-15-334) National Cancer Institute Application Receipt/Submission Dates: November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization |
Sustained Support for Informatics Resources for Cancer Research and Management (U24) (PAR-15-333) National Cancer Institute Application Receipt/Submission Dates: November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization |
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01) (PAR-15-332) National Cancer Institute Application Receipt/Submission Dates: November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization |
Advanced Development of Informatics Technologies for Cancer Research and Management (U24) (PAR-15-331) National Cancer Institute Application Receipt/Submission Dates: November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization. |
Single-Site Investigator-Initiated Clinical Trials (R61/R33) (PAR-16-405) National Heart, Lung, and Blood Institute Application Receipt/Submission Dates: October 11, 2017; February 13, 2018; June 14, 2018; October 11, 2018; February 13, 2019; June 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01) (RFA-MH-17-614) National Institute of Mental Health Application Receipt Dates: October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34) (RFA-MH-17-612) National Institute of Mental Health Application Receipt Dates: October 17,2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01) (RFA-MH-17-610) National Institute of Mental Health Application Receipt Dates: October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01) (RFA-MH-17-608) National Institute of Mental Health Application Receipt Dates: June 14, 2017; October 17,2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33) (RFA-MH-17-606) National Institute of Mental Health Application Receipt Dates: June 14, 2017; October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33) (RFA-MH-17-604) National Institute of Mental Health Application Receipt Dates: June 14, 2017; October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp) (PA-17-248) |
Cancer-related Behavioral Research through Integrating Existing Data (R21) (PAR-16-255) National Cancer Institute Application Receipt/Submission Dates: June 15, 2017; February 15, 2018; June 15 2018; February 15, 2019; June 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Discovery of Genetic Basis of Monogenic Heart, Lung, Blood, and Sleep Disorders (X01) (PAR-15-314) National Heart, Lung, and Blood Institute Application Receipt/Submission Dates: June 15, 2017; June 15, 2018 , by 5:00 PM local time of applicant organization. |
Paul Calabresi Career Development Award for Clinical Oncology (K12) (PAR-16-189) National Cancer Institute Application Receipt/Submission Dates: June 15, 2017; June 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Novel Nucleic Acid Sequencing Technology Development (R21) (RFA-HG-15-031) National Human Genome Research Institute Application Receipt Dates: June 15, 2017, by 5:00 PM local time of applicant organization. |
Novel Nucleic Acid Sequencing Technology Development (R01) (RFA-HG-15-032) National Human Genome Research Institute Application Receipt Dates: June 15, 2017, by 5:00 PM local time of applicant organization. |
Novel Nucleic Acid Sequencing Technology Development (R43/R44) (RFA-HG-15-033) National Human Genome Research Institute Application Receipt Dates: June 15, 2017, by 5:00 PM local time of applicant organization. |
Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33) (RFA-MH-17-600) National Institute of Mental Health Application Receipt Dates: June 15, 2017; October 15, 2017, February 15, 2018, June 15, 2018, October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03) (RFA-HL-16-020) National Heart, Lung, and Blood Institute Application Receipt Dates: June 15, 2017; October 19, 2017; February 15, 2018; June 15, 2018, by 5:00 PM local time of applicant organization. |
Developing Interventions for Health-Enhancing Physical Activity (R21/R33) (PAR-14-321) Office of Disease Prevention National Center for Complementary and Alternative Medicine National Cancer Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism Office of Behavioral and Social Science Research Office of Research on Women's Health For new applications: June 16, 2017 For resubmission application: July 16, 2017 |
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44) (RFA-HL-16-009) National Heart, Lung, and Blood Institute Application Receipt Date: June 19, 2017, by 5:00 PM local time of applicant organization. |
NIDDK Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34) (PAR-15-068) National Institute of Diabetes and Digestive and Kidney Diseases Application Due Date: June 19, 2017 AIDS Application Due Date: September 7, 2017 |
Basic Cancer Research in Cancer Health Disparities (R01) (PAR-15-093) National Cancer Institute Application Receipt/Submission Dates: June 19, 2017; November 17, 2017, by 5:00 PM local time of applicant organization. |
Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) (PAR-15-092) National Cancer Institute Application Receipt/Submission Dates: June 19, 2017; November 17, 2017, by 5:00 PM local time of applicant organization. |
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) (PAR-16-320) National Institute on Deafness and Other Communication Disorders Application Receipt/Submission Dates: June 19, 2017; October 17, 2017; February 15, 2018; June 19, 2018; October 19, 2018; February 15, 2019; and June 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers (R01) (RFA-DE-18-004) |
Resource-Related Research Projects in the Epidemiology and Prevention of Pediatric Injury (R24) (PAR-17-228) |
Limited Competition: Genomics and Informatics Center for the SubPopulations and InteRmediate Outcomes Measures In COPD Study (SPIROMICS) (U24) (RFA-HL-18-011) |
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01) (RFA-MH-18-200) |
Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33) (RFA-DA-18-005) |
Strategies to Increase Delivery of Guideline-Based Care to Populations with Health Disparities (R01) (PAR-15-279) National Heart, Lung, and Blood Institute Application Receipt/Submission Dates: June 21, 2017; October 20, 2017; and June 21, 2018, by 5:00 PM local time of applicant organization. |
Image-guided Drug Delivery (R01) (PAR-16-044) National Cancer Institute National Institute of Biomedical Imaging and Bioengineering Application Receipt/Submission Dates: June 21, 2017; November 22, 2017; June 21, 2018; November 22, 2018, by 5:00 PM local time of applicant organization. |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate the Discovery of Neurotherapeutics (R21/R33) (RFA-NS-16-013) National Institute of Neurological Disorders and Stroke National Institute on Drug Abuse Application Receipt Dates: June 21, 2017; October 18, 2017 , by 5:00 PM local time of applicant organization. |
Limited Competition: National Swine Resource and Research Center (U42) (PAR-17-255) |
Integrating Biospecimen Science into Clinical Assay Development (U01) (PAR-16-166) National Cancer Institute Application Receipt/Submission Date: June 22, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) (PAR-15-053) National Cancer Institute Application Receipt/Submission Dates: June 22, 2017; November 30, 2017 |
Emerging Questions in Cancer Systems Biology (U01) (PAR-16-131) National Cancer Institute Application Receipt/Submission Dates: June 23, 2017; November 24, 2017; June 22, 2018; November 23, 2018, by 5:00 PM local time of applicant organization |
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3) (PAR-16-065) National Institute of Mental Health Application Receipt/Submission Dates: June 23, 2017, October 24, 2017, February 23, 2018, June 26, 2018, October 24, 2018, by 5:00 PM local time of applicant organization |
National Cooperative Drug/Device Discovery/Development Groups (U01) (PAR-17-185)National Institute of Mental Health National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Application Receipt/Submission Dates: June 23, 2017; October 23, 2017; February 23, 2018; June 22, 2018; October 23, 2018; February 22, 2019; June 24, 2019; October 23, 2019; February 24, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19) (PAR-17-186) |
Native American Research Centers for Health (NARCH) (S06) (PAR-16-297) National Institute of General Medical Sciences National Cancer Institute National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities Office of Research on Women's Health Application Receipt/Submission Date: June 24, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R43/R44) (RFA-HL-17-023) |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R41/R42) (RFA-HL-17-024) |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U54) (RFA-HL-17-025) |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM1) (RFA-HL-17-026) |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UC4) (RFA-HL-17-027) |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U24) (RFA-HL-17-028) |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R01) (RFA-HL-17-029) |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R24) (RFA-HL-17-030) |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM2) (RFA-HL-17-031) |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P50) (RFA-HL-17-032) |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P41) (RFA-HL-17-033) |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U01) (RFA-HL-17-034) |
NCI Small Grants Program for Cancer Research (NCI Omnibus R03) (PAR-16-416) National Cancer Institute Application Receipt/Submission Dates: June 27, 2017; October 26, 2017; February 27, 2018; June 29, 2018; October 26, 2018; February 26, 2019; June 28, 2019; October 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on dates |
Neural Regulation of Cancer (R01) (PAR-16-245) National Cancer Institute Application Receipt/Submission Dates: June 27, 2017; October 26, 2017; February 22, 2018; June 27, 2018; October 27, 2018; February 22, 2019; June 27, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Neural Regulation of Cancer (R21) (PAR-16-246) National Cancer Institute Application Receipt/Submission Dates: June 27, 2017; October 26, 2017; February 22, 2018; June 27, 2018; October 25, 2018; February 22, 2019; June 27, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Human-Animal Interaction (HAI) Research (R21) (PAR-17-229) |
Human-Animal Interaction (HAI) Research (R03) (PAR-17-230) |
Human-Animal Interaction (HAI) Research (R01) (PAR-17-231) |
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01) (PAR-17-167) |
Ancillary Studies to Identify Behavioral and/or Psychological Phenotypes Contributing to Obesity (R01) (PAR-16-304) National Institute of Diabetes and Digestive and Kidney Diseases Office of Behavioral and Social Science Research Office of Disease Prevention Application Receipt/Submission Dates: June 28, 2017; February 28, 2018; June 28, 2018; February 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Research Answers to NCI's Provocative Questions (R01) (RFA-CA-17-017) |
Research Answers to NCI's Provocative Questions (R21) (RFA-CA-17-018) |
Revision Applications to NCI-supported R01 Awards to Include Research on the NCI's Provocative Questions (R01) (RFA-CA-17-019) |
Revision Applications to National Cancer Institute (NCI)-supported U01 Awards to Include Research on the NCI's Provocative Questions (U01) (RFA-CA-17-020) |
Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCI's Provocative Questions (P01) (RFA-CA-17-021) |
Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCI's Provocative Questions (P50) (RFA-CA-17-022) |
Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R01) (RFA-HD-18-019) |
Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R21) (RFA-HD-18-020) |
Centers of Excellence for Training in Glycosciences (K12) (RFA-HL-18-013) |
National Centers for Cryoelectron Microscopy (U24) (RFA-RM-17-002) |
Environmental influences on Placental Origins of Development (ePOD) (R01) (RFA-ES-17-005) |
NIDDK Central Repositories Non-renewable Sample Access (X01) (PAR-14-301) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt/Submission Date: June 30, 2017 |
Data Coordinating Center for the NICHD Neonatal Research Network (U24) (RFA-HD-18-010) |
Identification of Reproductive-Tract Specific Proteins/Transcripts for the Development of Male and Female Non-Hormonal Contraceptives (R01) (RFA-HD-18-002) |
Point of Care Technologies for the Evaluation and Management of Obstetrics, Neonatal, and Pediatric Critical Care Patients, and for Patients with Disorders of Reproductive Tract and Infertility (R43) (RFA-HD-18-028) |
Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp) (PA-17-286) |
Identification of Genetic and Genomic Variants by Next-Gen in Sequencing Non-human Animal Models (U01) (PAR-15-120) National Institute on Drug Abuse Application Receipt/Submission Dates: June 30, 2017; October 20, 2017; March 1, 2018, by 5:00 PM local time of applicant organization. |
Limited Competition: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program (Admin Supp) (PA-16-328) National Center for Advancing Translational Sciences Application Receipt/Submission Dates: July 1, 2017; November 1, 2017; March 1, 2018; July 1, 2018; November 1, 2018; March 1, 2019 by 5:00 PM local time of applicant organization |
NEI Administrative Supplements to Small Business Innovative Research (SBIR) Grants for the Procurement of Expertise in the Federal Regulatory Approval Process for New Drugs and/or Devices (Admin Supp) (PA-15-132) National Eye Institute Application Receipt/Submission Date: July 1, 2017, by 5:00 PM local time of applicant organization. |
Noise-Induced Cochlear Synaptopathy: Basic Studies Informing Potential Therapies (R01) (PAR-16-170) National Institute on Deafness and Other Communication Disorders Application Receipt/Submission Date: July 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
NIDCR Dental Specialty and PhD Program (DSPP)(K12) (RFA-DE-18-003) |
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01) (PAR-15-115) National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt/Submission Dates: July 3, 2017, November 1, 2017, by 5:00 PM local time of applicant organization, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. |
NIAMS Clinical Trial Implementation Cooperative Agreement (U01) (PAR-16-447) National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt/Submission Dates: July 3, 2017; November 1, 2017; March 2, 2018; July 2, 2018; November 1, 2018; March 1, 2019; July 1, 2019;November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
NIAMS Clinical Trial Planning Grant (R34) (PAR-16-446) National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt/Submission Dates: July 3, 2017; November 1, 2017; March 2, 2018; July 2, 2018; November 1, 2018; March 1, 2019; July 1, 2019; November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Testing Interventions for Health-Enhancing Physical Activity (R01) (PAR-14-315) Office of Disease Prevention National Cancer Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development Office of Behavioral and Social Science Research Office of Research on Women's Health Resubmission application: July 5, 2017 AIDS Application Due Date: September 7, 2017 |
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01) (PAR-17-005) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Dental and Craniofacial Research Application Receipt/Submission Dates: July 5, 2017 (renewal, resubmission, revision); October 5, 2017 (new) and November 5, 2017 (renewal, resubmission, revision); June 5, 2018 (new) and July 5, 2018 (renewal, resubmission, revision); October 5, 2018 (new) and November 5, 2018 (renewal, resubmission, revision); June 5, 2019 (new) and July 5, 2019 (renewal, resubmission, revision); October 5, 2019 (new) and November 5, 2019 (renewal, resubmission, revision), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Genetic Susceptibility and Variability of Human Structural Birth Defects (R01) (PAR-17-236) |
Establishment of Research Centers to Investigate the FVIII Immune Response in Patients with Hemophilia A (U54) (RFA-HL-18-014) |
PsychENCODE: Non-coding Functional Elements in the Human Brain and their Role in the Development of Psychiatric Disorders (U01) (PAR-17-257) |
PsychENCODE: Non-coding Functional Elements in the Human Brain and their Role in the Development of Psychiatric Disorders (Collaborative U01) (PAR-17-258) |
SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44) (RFA-CA-17-024) |
Integrative Computational Biology for Analysis of NHLBI TOPMed Data (RFA-HL-18-020) |
Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (UH3) (PAR-15-096) National Cancer Institute Application Receipt/Submission Dates: July 7, 2017; October 6, 2017, by 5:00 PM local time of applicant organization. |
Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (UH2/UH3) (PAR-15-095) National Cancer Institute Application Receipt/Submission Dates: July 7, 2017; October 6, 2017, by 5:00 PM local time of applicant organization. |
Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (Admin Supp) (PA-15-264) National Cancer Institute Application Receipt/Submission Dates: July 7, 2017; October 6, 2017; March 26, 2018; July 8, 2018, by 5:00 PM local time of applicant organization. |
Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33) (RFA-AR-17-009) National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date: July 10, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date |
Imaging and Biomarkers for Early Cancer Detection (U01) (PAR-16-089) National Cancer Institute Application Receipt/Submission Dates: July 10, 2017; December 11, 2017; July 10, 2018; December 11, 2018, by 5:00 PM local time of applicant organization |
Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43) (RFA-AR-18-005) |
Time-Sensitive Obesity Policy and Program Evaluation (R01) (PAR-15-346) National Institute of Diabetes and Digestive and Kidney Diseases National Cancer Institute Eunice Kennedy Shriver National Institute of Child Health and Human Development Office of Behavioral and Social Science Research Application Receipt/Submission Dates: July 10, 2017; August 10, 2017; September 11, 2017; October 10, 2017; November 13, 2017; December 11, 2017; January 1, 2018; February 13, 2018; March 13, 2018; April 10, 2018; May 10, 2018; June 11, 2018; July 10, 2018; August 10, 2018; and September 13, 2018, by 5:00 PM local time of applicant organization. |
Translational Studies on Adducts for Cancer Risk Identification and Prevention (U01) (PAR-15-307) National Cancer Institute Application Receipt/Submission Dates: July 11, 2017, November 21, 2017; July 11, 2018, by 5:00 PM local time of applicant organization. |
Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R01) (PAR-15-308) National Cancer Institute National Institute of Environmental Health Sciences Application Receipt/Submission Dates: July 11, 2017, November 21, 2017; July 11, 2018, by 5:00 PM local time of applicant organization. |
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01) (PAR-17-003) National Cancer Institute Application Receipt/Submission Dates: July 11, 2017; October 27, 2017; February 27, 2018; July 11, 2018; October 26, 2018; February 27, 2019; July 11, 2019; October 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01) (PAR-17-234) |
Mechanisms and Consequences of Sleep Disparities in the U.S. (R21) (PAR-17-235) |
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01) (PAR-17-274) |
Genomic Community Resources (U24) (PAR-17-273) |
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11) (PAR-15-131) National Institute of Allergy and Infectious Diseases Application Receipt/Submission Date: July 14, 2017 |
HIV Vaccine Research and Design (HIVRAD) Program (P01) (PAR-15-164) National Institute of Allergy and Infectious Diseases Application Receipt/Submission Dates: July 14, 2017, by 5:00 PM local time of applicant organization. |
Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01) (PAR-16-111) National Cancer Institute Application Receipt/Submission Dates: July 14, 2017; December 14, 2017, by 5:00 PM local time of applicant organization |
Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4) (RFA-DK-17-507) |
Limited Competition: Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes In The Young Study (TEDDY) (UC4) (RFA-DK-17-508) |
Pre-application: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT1) (RFA-RM-15-003) NIH Roadmap Initiatives Application Receipt Dates: July 14, 2017; September 15, 2017; November 15, 2017; January 15, 2018 |
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01) (PAR-16-455) National Institute on Drug Abuse National Cancer Institute National Institute on Alcohol Abuse and Alcoholism Application Receipt/Submission Dates: July 18, 2017; November 13, 2017; July 17, 2018; November 13, 2018; July 17, 2019; November 13, 2019; July 17, 2020; November 13, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34) (PAR-16-456) National Institute on Drug Abuse National Institute on Alcohol Abuse and Alcoholism Application Receipt/Submission Dates: July 18, 2017; November 13, 2017; July 17, 2018; November 13, 2018; July 17, 2019; November 13, 2019; July 17, 2020; November 13, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Reducing the Duration of Untreated Psychosis in the United States (R34) (PAR-16-264) National Institute of Mental Health Application Receipt/Submission Dates: July 18, 2017; November 17, 2017; March 19, 2018; July 18, 2018; November 19, 2018; March 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Reducing the Duration of Untreated Psychosis in the United States (R01) (PAR-16-265) National Institute of Mental Health Application Receipt/Submission Dates: July 18, 2017; November 17, 2017; March 19, 2018; July 18, 2018; November 19, 2018; March 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Center for Coordination of Analytics, Science, Enhancement , and Logistics (CASEL) in Tobacco Regulatory Science (U54) (RFA-OD-17-002) |
Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54) (RFA-OD-17-003) |
Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54) (RFA-OD-17-006) |
NCI Clinical and Translational Exploratory/Developmental Studies (R21) (PAR-16-176) National Cancer Institute Application Receipt/Submission Dates: July 19, 2017; November 22, 2017; March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Alzheimer's-related Resource Centers for Minority Aging Research (AD-RCMAR) (P30) (RFA-AG-18-002) |
Resource Centers for Minority Aging Research (P30) (RFA-AG-18-003) |
Resource Centers for Minority Aging (RCMAR) Coordinating Center (R24) (RFA-AG-18-004) |
Cystic Fibrosis Research and Translation Center (P30) (RFA-DK-17-007) |
NINR Clinical Trial Planning Grant (R34) (PAR-17-133) |
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01) (PAR-16-430) National Institute on Drug Abuse Application Receipt/Submission Dates: July 25, 2017; March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Research Education Program Grants for CryoEM Curriculum Development (R25) (RFA-RM-17-004) |
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3) (RFA-DA-18-003) |
Grand Opportunity in Medications Development for Substance-Use Disorders (U01) (PAR-16-431) National Institute on Drug Abuse Application Receipt/Submission Dates: July 25, 2017; March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research (Admin Supp) (PA-17-143) |
Limited Competition: National NeuroAIDS Tissue Consortium (NNTC) Clinical Sites (U24) (RFA-MH-18-250) |
Limited Competition: National NeuroAIDS Tissue Consortium (NNTC) Data Coordinating Center (U24) (RFA-MH-18-251) |
Global Infectious Disease Research Training Program (D43) (PAR-17-057) John E. Fogarty International Center National Institute of Allergy and Infectious Diseases Application Receipt/Submission Dates: July 27, 2017; July 26, 2018; July 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-17-058) John E. Fogarty International Center Application Receipt/Submission Dates: July, 27, 2017; July 26, 2018; July 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
SBIR E-learning for HAZMAT and Emergency Response (R43/R44) (RFA-ES-17-004) |
Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3) (PAR-15-267) National Institute on Drug Abuse Application Receipt/Submission Dates: July 28, 2017; March 28, 2018, by 5:00 PM local time of applicant organization. |
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1) (RFA-DA-18-001) |
Limited Competition: Exploratory CTSA Collaborative Innovation Awards (R21) (PAR-16-343) National Center for Advancing Translational Sciences Application Receipt/Submission Dates: July 31, 2017, November 29, 2017, March 29, 2018, July 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Cellular Therapies for Treatment of Radiation Injuries (U01) (RFA-AI-17-001) |
Dysregulation of Immune Cell Regulatory Pathways by Mtb in the Context of HIV Infection (R61/R33) (RFA-AI-17-010) |
Innovation for HIV Vaccine Discovery (R01) (PAR-17-263) |
Centers for AIDS Research (P30) (PAR-17-237) |
Developmental Centers for AIDS Research (P30) (PAR-17-238) |
AHRQ Conference Grant Programs (R13) (PA-16-453) Agency for Healthcare Research and Quality Application Receipt/Submission Dates: August 1 and November 1 by 5:00 PM local time of applicant organization |
BD2K Open Educational Resources for Skills Development in Biomedical Big Data Science (R25) (RFA-HG-16-016) National Human Genome Research Institute John E. Fogarty International Center National Center for Advancing Translational Sciences National Cancer Institute National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Library of Medicine Office of Behavioral and Social Science Research Office of Disease Prevention Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Office of Research on Women's Health The Common Fund/Office of Strategic Coordination Application Receipt Dates: August 2, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
NeuroNEXT Clinical Trials (U01) (PAR-16-155) National Institute of Neurological Disorders and Stroke Application Receipt/Submission Dates: August 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33) (RFA-AT-18-001) |
Regional Consortia for High Resolution Cryoelectron Microscopy (U24) (RFA-GM-17-005) |
ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (PRECluDE) (U01) (RFA-HL-18-007) |
Planning Grants for Clinical Trials of High Relevance to the NIGMS Mission (R34) (PAR-17-268) |
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21) (PAR-17-187) |
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03) (PAR-17-188) |
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01) (PAR-17-189) |
Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01) (RFA-AR-18-002) |
Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R21) (RFA-AR-18-003) |
Sleep Health and Circadian Biology in HIV-Related Comorbidities (R01) (RFA-HL-18-005) |
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) (PAR-17-201) |
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3) (PAR-17-205) |
Limited Competition: Palliative Care Research Cooperative (PCRC) (U2C) (RFA-NR-17-001) |
Wearable to Track Recovery and Relapse Factors for People w/ Addiction(R43/R44) (RFA-DA-18-010) |
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) (PAR-15-297) National Cancer Institute Application Receipt/Submission Dates: August 15, 2017; February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization. |
Extracellular Vesicles and Substance Use Disorders (R21) (PAR-17-242) |
Extracellular Vesicles and Substance Use Disorders (R01) (PAR-17-250) |
Inter-organelle Communication in Cancer (R01) (PAR-17-203) |
Inter-organelle Communication in Cancer (R21) (PAR-17-204) |
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01) (PAR-16-020) National Institute of Neurological Disorders and Stroke Application Receipt/Submission Dates: August 17, 2017; February 15, 2018; August 17, 2018, by 5:00 PM local time of applicant organization |
Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R01) (RFA-DA-18-008) |
Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R21) (RFA-DA-18-009) |
Tobacco Regulatory Science (R01) (RFA-OD-17-007) |
Tobacco Regulatory Science Small Grant Program for New Investigators (R03) (RFA-OD-17-008) |
Tobacco Regulatory Science (R21) (RFA-OD-17-009) |
Translational Outcomes Project in Neurotrauma (TOP-NT) (UG3/UH3) (RFA-NS-17-023) |
Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01) (RFA-DA-18-002) |
Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36) (PAR-15-181) National Institute of Mental Health Application Receipt/Submission Dates: August 22, 2017, December 22, 2017, April 23, 2018, by 5:00 PM local time of applicant organization. |
Nasal Delivery of CNS Therapeutics (R43/R44) (RFA-DA-18-006) |
Nasal Delivery of CNS Therapeutics (R41/R42) (RFA-DA-18-007) |
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43) (PAR-16-279) John E. Fogarty International Center National Cancer Institute National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Mental Health Application Receipt/Submission Dates: August 23, 2017; August 23, 2018), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11) (PAR-16-280) John E. Fogarty International Center National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Application Receipt/Submission Dates: August 23, 2017; August 23, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Planning Grant for Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D71) (PAR-16-281) John E. Fogarty International Center National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Mental Health Application Receipt/Submission Dates: August 23, 2017; August 23, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Lasker Clinical Research Scholars Program Si2/R00 (PAR-17-254) |
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21) (PAR-16-292) John E. Fogarty International Center National Cancer Institute National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Office of Behavioral and Social Science Research Application Receipt/Submission Date: August 31, 2017; August 31, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp) (PA-16-013) National Center for Complementary and Integrative Health Application Receipt/Submission Dates: April 1 and September 1, 2016-2018 by 5:00 PM local time of applicant organization |
NIH Director's Pioneer Award Program (DP1) (RFA-RM-17-005) |
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01) (RFA-MH-18-300) |
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21) (RFA-MH-18-301) |
Biomarkers Discovery In Parkinsonism (U01) (PAR-16-112) National Institute of Neurological Disorders and Stroke Application Receipt/Submission Dates: September 6, 2017; September 6, 2018, by 5:00 PM local time of applicant organization |
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Tuberculosis Vaccine Design (R01) (PAR-16-254) National Institute of Allergy and Infectious Diseases Application Receipt/Submission Dates: September 6, 2017; September 6, 2018 , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Biological Comparisons in Patient-Derived Models of Cancer (U01) (PAR-16-344) National Cancer Institute Application Receipt/Submission Dates: September 6, 2017; March 7, 2018; September 6, 2018; March 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
NIMH Research Education Mentoring Programs for HIV/AIDS Researchers (R25) (PAR-15-145) National Institute of Mental Health Application Receipt/Submission Date: Sepember 7, 2017, by 5:00 PM local time of applicant |
Ethical Issues in Research on HIV/AIDS and its Co-Morbidities (R21) (PAR-15-275) National Institute of Allergy and Infectious Diseases National Cancer Institute National Institute of Mental Health Application Receipt/Submission Dates: September 7, 2017; January 8, 2018, by 5:00 PM local time of applicant organization. |
Ethical Issues in Research on HIV/AIDS and its Co-Morbidities (R01) (PAR-15-274) National Institute of Allergy and Infectious Diseases National Cancer Institute National Institute of Mental Health Application Receipt/Submission Dates: September 7, 2017; January 8, 2018, by 5:00 PM local time of applicant organization. |
Ethical, Legal and Policy Issues in HIV Research with Key Populations (R21) (PAR-15-327) National Institute of Allergy and Infectious Diseases National Institute of Mental Health Application Receipt/Submission Dates: September 7, 2017; January 8, 2018; September 7, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. |
Ethical, Legal and Policy Issues in HIV Research with Key Populations (R01) (PAR-15-328) National Institute of Allergy and Infectious Diseases National Institute of Mental Health Application Receipt/Submission Dates: September 7, 2017; January 8, 2018; September 7, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. |
NIH Director's New Innovator Award Program (DP2) (RFA-RM-17-006) |
Enhancing Developmental Biology Research at Academic Research Enhancement Award Eligible Institutions (R15) (PAR-15-149) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt/Submission Dates: September 11, 2017, by 5:00 PM local time of applicant organization. |
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54) (PAR-15-146) National Institute of Neurological Disorders and Stroke National Eye Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Environmental Health Sciences Application Receipt/Submission Dates: September 12, 2017, by 5:00 PM local time of applicant organization. |
Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3) (PAR-17-128) |
Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01) (PAR-16-128) National Institute of Neurological Disorders and Stroke National Eye Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Environmental Health Sciences Application Receipt/Submission Dates: September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization |
Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01) (PAR-16-129) National Institute of Neurological Disorders and Stroke National Eye Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Environmental Health Sciences Application Receipt/Submission Dates: September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization |
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54) (PAR-16-329) National Institute of Neurological Disorders and Stroke Application Receipt/Submission Dates: September 12, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01) (PAR-16-330) National Institute of Neurological Disorders and Stroke Application Receipt/Submission Dates: September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01) (PAR-16-331) National Institute of Neurological Disorders and Stroke Application Receipt/Submission Date: September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01) (PAR-17-129) |
Bioengineering Research Partnerships (U01) (PAR-16-116) National Institute of Biomedical Imaging and Bioengineering National Cancer Institute National Eye Institute National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Environmental Health Sciences National Institute of Neurological Disorders and Stroke Application Receipt/Submission Dates: September 13, 2017, May 8, 2018, September 13, 2018, by 5:00 PM local time of applicant organization |
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24) (PAR-16-301) National Heart, Lung, and Blood Institute Application Receipt/Submission Dates: September 13, 2017; January 11, 2018; May 13, 2018; September 13, 2018; January 11, 2019; May 13, 2019; September 13, 2019 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates |
NIAID Clinical Trial Implementation Grant (R01) (PAR-16-269) National Institute of Allergy and Infectious Diseases Application Receipt/Submission Dates: September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
NIAID Clinical Trial Implementation Cooperative Agreement (U01) (PAR-16-270) National Institute of Allergy and Infectious Diseases Application Receipt/Submission Dates: September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44) (PAR-16-271) National Institute of Allergy and Infectious Diseases Application Receipt/Submission Dates: September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization |
NIAID Clinical Trial Planning Grant (R34) (PAR-16-272) National Institute of Allergy and Infectious Diseases Application Receipt/Submission Dates: September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Developmental AIDS Research Center on Mental Health and HIV/AIDs (P30) (PAR-15-196) National Institute of Mental Health Application Receipt/Submission Date: September 14, 2017, by 5:00 PM local time of applicant organization. |
AIDS Research Center on Mental Health and HIV/AID (P30) (PAR-15-197) National Institute of Mental Health Application Receipt/Submission Date: September 14, 2017 by 5:00 PM local time of applicant organization. |
Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (UG3/UH3) (RFA-TR-17-002) |
Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses for Existing Molecules (UG3/UH3) (RFA-TR-17-003) |
NIH Director's Transformative Research Awards (R01) (RFA-RM-17-007) |
Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25) (RFA-HL-16-008) National Heart, Lung, and Blood Institute Application Receipt Date: September 18, 2017 |
T32 Training Program for Institutions That Promote Diversity (T32) (RFA-HL-16-007) National Heart, Lung, and Blood Institute Application Receipt Date: September 18, 2017 (resubmissions only) by 5:00 PM local time of applicant organization. |
Institutional Research and Academic Career Development Awards (IRACDA) (K12) (PAR-16-103) National Institute of General Medical Sciences Application Receipt/Submission Dates: September 19, 2017; September 19, 2018, by 5:00 PM local time of applicant organization |
Biophysical and Biomechanical Aspects of Embryonic Development (R21) (PAR-16-324) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt/Submission Dates: September 19, 2017; September 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Biophysical and Biomechanical Aspects of Embryonic Development (R01) (PAR-16-325) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt/Submission Dates: September 19, 2017; September 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01) (PAR-15-021) National Cancer Institute National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt/Submission Date: September 21, 2017 |
Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests (U01) (PAR-15-108) National Cancer Institute Application Receipt/Submission Date: September 21, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. |
Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests (U01) (PAR-17-146) |
The Pancreatic Cancer Detection Consortium (U01) (PAR-15-289) National Cancer Institute Application Receipt/Submission Dates: September 21, 2017, April 6, 2018, by 5:00 PM local time of applicant organization. |
NIH Director's Early Independence Awards (DP5) (RFA-RM-17-008) |
Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T90/R90) (PAR-15-101) National Institute of Dental and Craniofacial Research Application Receipt/Submission Date: September 25, 2017, by 5:00 PM local time of applicant organization. |
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T32) (PAR-15-102) National Institute of Dental and Craniofacial Research Application Receipt/Submission Date: September 25, 2017, by 5:00 PM local time of applicant organization. |
NIH StrokeNet Regional Coordinating Stroke Centers (U24) (PAR-17-276) |
NIDA Research Center of Excellence Grant Program (P50) (PAR-16-009) National Institute on Drug Abuse Application Receipt/Submission Dates: September 25, 2017; September 25, 2018, by 5:00 PM local time of applicant organization. |
Bridges to the Doctorate (R25) (PAR-16-109) National Institute of General Medical Sciences Application Receipt/Submission Dates: September 25, 2017; September 25, 2018. If the date falls on a week-end, the application is due the next business day, by 5:00 PM local time of applicant organization |
Bridges to the Baccalaureate (R25) (PAR-16-110) National Institute of General Medical Sciences Application Receipt/Submission Dates: September 25, 2017 September 25, 2018, by 5:00 PM local time of applicant organization |
Research Education: Bridges to the Doctorate (R25) (PAR-17-209) |
Bridges to the Baccalaureate Program (R25) (PAR-17-210) |
Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18) (PA-17-247) |
NIDA Core "Center of Excellence" Grant Program (P30) (PAR-17-121) |
nitiative to Maximize Research Education in Genomics: Courses for Skills Development (R25) (PAR-16-090) National Human Genome Research Institute Application Receipt/Submission Dates: September 26, 2017; January 25, 2018; May 25, 2018; September 26, 2018; and January 25, 2019, by 5:00 PM local time of applicant organization |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21) (RFA-CA-17-010) National Cancer Institute Application Receipt Date: September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33) (RFA-CA-17-013) National Cancer Institute Application Receipt Dates: September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Innovative Technologies for Cancer-Relevant Biospecimen Science (R21) (RFA-CA-17-012) National Cancer Institute Application Receipt Date: September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33) (RFA-CA-17-011) National Cancer Institute Application Receipt Date: September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Perception and Cognition Research to Inform Cancer Image Interpretation (R21) (PAR-17-124) |
Perception and Cognition Research to Inform Cancer Image Interpretation (R01) (PAR-17-125) |
Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Animal Species (R01) (PAR-16-366) Eunice Kennedy Shriver National Institute of Child Health and Human Development Department of Agriculture Application Receipt/Submission Dates: September 27, 2017; September 27, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
NICHD Laboratory of Developmental Biology (R24) (PAR-16-396) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt/Submission Dates: September 27, 2017, January 30, 2018, May 30, 2018, September 26, 2018, January 30, 2019, May 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Neuroskeletal Biology of the Dental and Craniofacial Skeletal System (R01) (RFA-DE-18-005) |
Neuroskeletal Biology of the Dental and Craniofacial Skeletal System (R21) (RFA-DE-18-006) |
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE)(P20) (PAR-16-241) National Institute of General Medical Sciences Application Receipt/Submission Dates: September 28, 2017; and September 28, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research (U01) (PAR-15-085) National Institute of Biomedical Imaging and Bioengineering Department of Energy Food and Drug Administration National Aeronautics and Space Administration National Cancer Institute National Human Genome Research Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Science Foundation Office of Behavioral and Social Science Research Office of Naval Research US Army Application Receipt/Submission Dates: September 29, 2017 (Applicants interested in DOE funding may wish to use the September due dates, see Section IV.6, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. |
NIDCD Clinical Research Center Grant (P50) (PAR-16-339) National Institute on Deafness and Other Communication Disorders Application Receipt/Submission Dates: October 2, 2017; February 1, 2018; June 1, 2018; October 1, 2018; February 1, 2019; June 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Novel Cell Non-autonomous Mechanisms of Aging (R01) (RFA-AG-18-009) |
Intramural NIGMS Postdoctoral Research Associate (PRAT) Program (FI2) (PAR-15-094) National Institute of General Medical Sciences Application Receipt/Submission Dates: October 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. |
Maximizing Investigators' Research Award for Early Stage Investigators (R35) (PAR-17-190) |
Intramural NIGMS Postdoctoral Research Associate (PRAT) Program (Fi2) (PA-16-130) National Institute of General Medical Sciences Application Receipt/Submission Dates: October 3, 2017; October 3, 2018, by 5:00 PM local time of applicant organization |
NIAMS Rheumatic Diseases Research Resource-based Centers (P30) (RFA-AR-18-004) |
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01) (PAR-17-215) |
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01) (PAR-17-093) |
Informatics Methodology and Secondary Analyses to Explore Shared Immunology Study Data in ImmPort (UH2) (PAR-16-253) National Institute of Allergy and Infectious Diseases Application Receipt/Submission Dates: October 4, 2017; October 4, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Selected Topics in Transfusion Medicine (R01) (PAR-16-440) National Heart, Lung, and Blood Institute Application Receipt/Submission Dates: October 5, 2017; February 5, 2018; October 5, 2018; February 5, 2019; October 5, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Diet and Physical Activity Assessment Methodology (R01) (PAR-15-170) National Institute of Diabetes and Digestive and Kidney Diseases National Cancer Institute National Heart, Lung, and Blood Institute National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Nursing Research Office of Dietary Supplements Application Receipt/Submission Dates: For new applications: October 5, 2017; and June 5, 2018 (alternating standard R01 receipt dates). For resubmission/renewal/revision applications: November 5, 2017; and July 5, 2018 (alternating standard R01 receipt dates) , by 5:00 PM local time of applicant organization. |
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24) (PAR-17-172) |
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3) (PAR-17-174) |
NCCIH Natural Product Phase II Clinical Trial Cooperative Agreement (U01) (PAR-17-216) |
NIDCD Research Career Enhancement Award for Established Investigators (K18) (PAR-16-346) National Institute on Deafness and Other Communication Disorders Application Receipt/Submission Dates: October 6, 2017; February 8, 2018; June 8, 2018; October 9, 2018; February 8, 2019; and June 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Building Evidence: Effective Palliative/End of Life Care Interventions (R01) (PAR-16-250) National Institute of Nursing Research Application Receipt/Submission Dates: October 9, 2017; June 11, 2018; October 8, 2018; June 10, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30) (PAR-16-247) National Institute of General Medical Sciences Application Receipt/Submission Dates: October 10, 2017; October 10, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Environmental Health Cohorts Maintenance and Infrastructure (R24) (RFA-ES-16-004) National Institute of Environmental Health Sciences Application Receipt Dates: October 10, 2017; October 10, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01) (PAR-16-380) National Cancer Institute Application Receipt/Submission Dates: October 10, 2017; April 11, 2018; October 10, 2018; April 11, 2019, October 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21) (PAR-16-257) National Cancer Institute Application Receipt/Submission Dates: October 10, 2017; April 11, 2018; October 10, 2018; April 11, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01) (PAR-16-317) National Cancer Institute Application Receipt/Submission Dates: October 10, 2017; April 11, 2018; October 10, 2018, April 11, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21) (PAR-16-318) National Cancer Institute Application Receipt/Submission Dates: October 10, 2017; April 11, 2018; October 10, 2018, April 11, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) (PAR-15-117) National Institute on Deafness and Other Communication Disorders Application Receipt/Submission Date: October 10, 2017, by 5:00 PM local time of applicant organization. |
NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01) (PAR-15-116) National Institute on Deafness and Other Communication Disorders Application Receipt/Submission Date: October 10, 2017, by 5:00 PM local time of applicant organization. |
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R24) (RFA-MH-17-256) National Institute of Mental Health National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Date: October 11, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Identification of Mechanisms Mediating the Effects of Sleep on Diabetes-Related Metabolism in Humans (R01) (RFA-DK-16-005) National Institute of Diabetes and Digestive and Kidney Diseases Office of Research on Women's Health Application Receipt Date: October 11, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21) (PAR-16-248) National Cancer Institute Application Receipt/Submission Dates: October 11, 2017; June 13, 2018; October 11, 2018, June 13, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01) (PAR-16-249) National Cancer Institute Application Receipt/Submission Dates: October 11, 2017; June 13, 2018; October 11, 2018, June 13, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) (PAR-16-300) National Heart, Lung, and Blood Institute Application Receipt/Submission Dates: October 11, 2017; February 13, 2018; June 13, 2018; October 11, 2018; February 13, 2019; June 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
FDA Scientific Conference Grant Program (R13) (PAR-16-378) Food and Drug Administration Application Receipt/Submission Dates: October 12, 2017 by 11:59 PM Eastern Time. April 12, 2018 and October 12, 2018 by 11:59 PM Eastern Time. April 12, 2019 and October 11, 2019 by 11:59 PM Eastern Time |
Occupational Safety and Health Education and Research Centers (T42) (PAR-15-303) National Institute for Occupational Safety and Health Application Receipt/Submission Dates: October 13, 2017, October 11, 2018, October 18, 2019 by 5:00 PM EST. |
BRAIN Initiative Cell Census Network (BICCN) - Specialized Center on Human and Non-Human Primate Brain Cell Atlases (U01) (RFA-MH-17-210) National Institute of Mental Health National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Dates: October 13, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21) (RFA-HL-17-015) National Heart, Lung, and Blood Institute Application Receipt Date: October 13, 2017; January 10, 2018; May 10, 2018; October 10, 2018; January 10, 2019; May 10, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
BRAIN Initiative Cell Census Network (BICCN) - Specialized Center on Mouse Brain Cell Atlas (U01) (RFA-MH-17-230) National Institute of Mental Health National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Dates: October 13, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01) (PAR-16-276) National Cancer Institute Application Receipt/Submission Dates: October 13, 2017; June 13, 2018; October 15, 2018; June 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01) (RFA-FD-15-001) Food and Drug Administration Office of Orphan Products Development Application Due Dates: February 7, 2018 by 11:59 PM Eastern Time. Resubmission Due Dates: October 16, 2017; October 15, 2018 by 11:59 PM Eastern Time. |
Selected Topics in Transfusion Medicine (R21) (PAR-16-441) National Heart, Lung, and Blood Institute Application Receipt/Submission Dates: October 16, 2017; February 16, 2018; October 16, 2018; February 16, 2019; October 16, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Diet and Physical Activity Assessment Methodology (R21) (PAR-15-171) National Institute of Diabetes and Digestive and Kidney Diseases National Cancer Institute National Heart, Lung, and Blood Institute National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Nursing Research Office of Dietary Supplements Application Receipt/Submission Dates: For new applications: October 16, 2017; and June 16, 2018 (alternating standard due dates). For resubmission applications: November 16, 2017; and July 16, 2018 (alternating standard due dates), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. |
Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21) (RFA-HL-17-022) National Heart, Lung, and Blood Institute Application Receipt Dates: October 17, 2017; February 15, 2018; October 17, 2018; February 15, 2019; October 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19) (RFA-NS-17-018) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Application Receipt Date: October 17, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (U01) (RFA-NS-17-003) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date |
BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01) (RFA-NS-17-004) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date |
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3) (RFA-NS-17-005) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date |
BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3) (RFA-NS-17-006) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date |
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44) (RFA-NS-17-007) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization |
Basic Research in Calcific Aortic Valve Disease (R01) (RFA-HL-18-010) |
BRAIN Initiative: SBIR Direct to Phase II Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44) (RFA-NS-17-008) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization |
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01) (PAR-17-184) |
Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24) (PAR-16-104) National Institute of General Medical Sciences Application Receipt/Submission Dates: October 18, 2017; October 18, 2018, by 5:00 PM local time of applicant organization |
Big Data to Knowledge (BD2K) Community-based Data and Metadata Standards Efforts (R24) (RFA-ES-16-010) National Institute of Environmental Health Sciences National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Library of Medicine Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Office of Research on Women's Health The Common Fund/Office of Strategic Coordination Application Receipt Dates: October 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (U34) (RFA-HL-18-008) |
Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (X01) (RFA-HL-18-009) |
Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03) (PAR-16-268) National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt/Submission Date: October 19, 2017; February 19, 2018; October 19, 2018; February 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1) (PAR-16-357) National Institute on Drug Abuse Application Receipt/Submission Dates: October 19, 2017; October 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans Resource Access (X01) (PAR-17-294) |
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24) (RFA-MH-17-255) National Institute of Mental Health National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Date: October 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76) (RFA-AG-18-006) |
Coordinating Center for Claude D. Pepper Older Americans Independence Centers (U24) (RFA-AG-18-008) |
Uncovering the Causes, Contexts, and Consequences of Elder Mistreatment (R01) (RFA-AG-18-010) |
Pragmatic Research in Healthcare Settings to improve Kidney Disease Prevention and Care (R18) (RFA-DK-17-008) |
Psychological, Behavioral, and Neurocognitive-Focused Ancillary Studies to the Molecular Transducers of Physical Activity in Humans Consortium (MoTrPAC) (U01) (RFA-DK-17-009) |
Occupational Safety and Health Training Project Grants (T03) (PAR-15-352) National Institute for Occupational Safety and Health Application Receipt/Submission Dates: October 26, 2017; October 26, 2018; October 24, 2019 |
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R24) (RFA-MH-17-257) National Institute of Mental Health National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Date: October 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Novel Genomic Technology Development (R43/R44) (PAR-16-016) National Human Genome Research Institute Application Receipt/Submission Dates: October 31, 2017, by 5:00 PM local time of applicant organization |
Novel Genomic Technology Development (R21) (PAR-16-015) National Human Genome Research Institute Application Receipt/Submission Dates: October 31, 2017, by 5:00 PM local time of applicant organization |
Novel Genomic Technology Development (R01) (PAR-16-014) National Human Genome Research Institute Application Receipt/Submission Dates: October 31, 2017, by 5:00 PM local time of applicant organization |
NIDDK Central Repositories Non-renewable Sample Access (X01) (PAR-17-270) |
George M. O'Brien Kidney Research Core Centers (P30) (RFA-DK-17-005) |
Tobacco Use and HIV in Low and Middle Income Countries (R01) (PAR-17-087) National Cancer Institute National Institute on Drug Abuse Application Receipt/Submission Dates: November 1, 2017; April 4, 2018; November 1, 2018; April 4, 2019, November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Tobacco Use and HIV in Low and Middle Income Countries (R21) (PAR-17-086) National Cancer Institute National Institute on Drug Abuse Application Receipt/Submission Dates: November 1, 2017; April 4, 2018; November 1, 2018; April 4, 2019, November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18) (PAR-17-178) |
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18) (PAR-17-177) |
Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34) (PAR-17-180) |
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2) (PAR-16-126) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt/Submission Dates: November 1, 2017; June 1, 2018; November 1, 2018, by 5:00 PM local time of applicant organization |
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54) (RFA-DK-17-006) |
Addressing Suicide Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01) (RFA-MH-18-400) |
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21) (PAR-17-293) |
Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp) (PA-15-109) National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt/Submission Date: November 6, 2017 by 5:00 PM local time of applicant organization. |
Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp) (PA-17-138) |
NIEHS SBIR Phase IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44) (RFA-ES-15-016) National Institute of Environmental Health Sciences Application Receipt Dates: November 13, 2017, by 5:00 PM local time of applicant organization. |
Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2) (RFA-DA-18-004) |
Social Epigenomics Research Focused on Minority Health and Health Disparities (R21) (PAR-16-356) National Institute on Minority Health and Health Disparities National Cancer Institute Application Receipt/Submission Dates: November 15, 2017; November 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01) (PAR-16-049) National Cancer Institute Application Receipt/Submission Dates: November 17, 2017, March 17, 2018; November 17, 2018, by 5:00 PM local time of applicant organization. |
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24) (PAR-16-385) National Cancer Institute Application Receipt/Submission Dates: November 17, 2017; June 14, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Innovative Research in Cancer Nanotechnology (IRCN) (R01) (PAR-17-240) |
Oral HIV Vaccination: Strategy Synergistic to Systemic Vaccination (R01) (RFA-DE-18-008) |
HIV pathogenesis and the oral microbiota (R01) (RFA-DE-18-007) |
NIOSH Centers of Excellence for Total Worker Health (U19) (PAR-15-361) National Institute for Occupational Safety and Health Application Receipt/Submission Dates: November 30, 2017; November 30, 2018 and November 29, 2019. |
New Informatics Tools and Methods to Enhance US Cancer Surveillance and Research (UG3/UH3) (PAR-16-349) National Cancer Institute Application Receipt/Submission Dates: November 30, 2017; April 16, 2018; November 30, 2018; April 16, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01) (PAR-16-105) National Cancer Institute Application Receipt/Submission Dates: November 30, 2017; May 30, 2018; November 30, 2018, by 5:00 PM local time of applicant organization |
Cooperative Research Agreements Related to the World Trade Center Health Program (U01) (PAR-16-098) National Institute for Occupational Safety and Health Application Receipt/Submission Dates: December 1, 2017; December 4, 2018; December 3, 2019 |
BD2K Research Education Curriculum Development: Data Science Overview for Biomedical Scientists (R25) (RFA-ES-16-011) National Institute of Environmental Health Sciences National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Library of Medicine Office of Behavioral and Social Science Research Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Office of Research on Women's Health The Common Fund/Office of Strategic Coordination Application Receipt Dates: December 1, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Specialized Alcohol Research Centers (P50) (RFA-AA-18-001) |
Silencing of HIV-1 Proviruses (R61/R33) (RFA-AI-17-013) |
Wearable Alcohol Biosensors (R43/R44) (PAR-16-410) National Institute on Alcohol Abuse and Alcoholism Application Receipt/Submission Dates: December 6, 2017; April 4, 2018; December 6, 2018; April 4, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Investigator Initiated Extended Clinical Trial (R01) (PAR-17-056) National Institute of Allergy and Infectious Diseases National Institute on Aging National Institute of General Medical Sciences Application Receipt/Submission Dates: December 7, 2017; March 7, 2018; December 7, 2018; March 7, 2019; December 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use Disorder and Alcohol-related Disorders (UT2) (PAR-15-073) National Institute on Alcohol Abuse and Alcoholism Application Receipt/Submission Date: December 11, 2017, by 5:00 PM local time of applicant organization. |
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use Disorder and Alcohol-related Disorders (UT2) (PAR-15-153) National Institute on Alcohol Abuse and Alcoholism Application Receipt/Submission Date: December 11, 2017 , by 5:00 PM local time of applicant organization. |
Emerging Global Leader Award (K43) (PAR-15-292) John E. Fogarty International Center National Human Genome Research Institute National Institute of Environmental Health Sciences National Institute of Mental Health Application Receipt/Submission Date: December 14, 2017, by 5:00 PM local time of applicant organization. |
Emerging Global Leader Award (K43) (PAR-17-001) John E. Fogarty International Center National Cancer Institute National Human Genome Research Institute National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke Office of Research on Women's Health Application Receipt/Submission Dates: December 14, 2017; and December 13, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02) (PAR-15-286) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Heart, Lung, and Blood Institute National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Office of Dietary Supplements Office of Research on Women's Health Application Receipt/Submission Date: December 15, 2017, by 5:00 PM local time of applicant organization. |
Integrated Approaches to HIV-Related Heart, Lung, Blood, and Sleep (HLBS) Comorbidities (R01) (RFA-HL-18-004) National Heart, Lung, and Blood Institute Application Receipt Date: December 15, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01) (PAR-16-262) National Institute of Allergy and Infectious Diseases National Institute of Mental Health Application Receipt/Submission Dates: January 4, 2018; January 4, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir (R01) (PAR-16-115) National Institute of Allergy and Infectious Diseases National Institute of Mental Health Application Receipt/Submission Date: January 9, 2018; May 8, 2018; January 9, 2019, by 5:00 PM local time of applicant organization |
HIV/AIDS Vaccine Scholars Program (K01) (PAR-16-347) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt/Submission Date: January 11, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
HIV/AIDS Vaccine Scholars Program (K01) (PAR-16-028) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt/Submission Date: January 11, 2018, by 5:00 PM local time of applicant organization |
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21) (PAR-15-360) National Institute of Allergy and Infectious Diseases Application Receipt/Submission Date: January 11, 2018, by 5:00 PM local time of applicant organization. |
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use Disorder and Alcohol-related Disorders (U44) (PAR-15-074) National Institute on Alcohol Abuse and Alcoholism Application Receipt/Submission Date: December 11, 2017, by 5:00 PM local time of applicant organization. |
Cardiovascular and Pulmonary Research on E-Cigarettes (R01) (RFA-HL-17-021) National Heart, Lung, and Blood Institute Application Receipt Date: January 16, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Maximizing Investigators' Research Award (R35) (PAR-17-094) |
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01) (PAR-16-021) National Heart, Lung, and Blood Institute Application Receipt/Submission Dates: January 19, 2018; January 18, 2019, by 5:00 PM local time of applicant organization |
Innovative Programs to Enhance Research Training (IPERT) (R25) (PAR-17-070) National Institute of General Medical Sciences Application Receipt/Submission Dates: January 23, 2018; January 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Centers of Biomedical Research Excellence (COBRE) (P20) (PAR-16-415) National Institute of General Medical Sciences Application Receipt/Submission Dates: January 24, 2018; and January 24, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Postbaccalaureate Research Education Program (PREP) (R25) (PAR-17-051) National Institute of General Medical Sciences Application Receipt/Submission Dates: January 24, 2018; January 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Support of NIGMS Program Project Grants (P01) (PAR-16-433) National Institute of General Medical Sciences Application Receipt/Submission Dates: January 25, 2018; and May 25, 2018 by 5:00 PM local time of applicant organization, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Revision Awards to Institutional Training Programs to Advance Research on Alzheimers Disease and Alzheimer's Disease Related Dementias (T32) (PAR-17-072) National Institute on Aging National Institute of Nursing Research Application Receipt/Submission Dates: January 25, 2018; and January 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
NIA Program Project Applications (P01) (PAR-16-358) National Institute on Aging Application Receipt/Submission Dates: January 25, 2018; May 25, 2018; January 25, 2019; May 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Support of Competitive Research (SCORE) Research Continuance Award (SC3) (PAR-16-437) National Institute of General Medical Sciences Application Receipt/Submission Dates: January 25, 2018; May 25, 2018; January 25, 2019; May 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Support of Competitive Research (SCORE) Pilot Project Award (SC2) (PAR-16-438) National Institute of General Medical Sciences National Cancer Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute of Allergy and Infectious Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt/Submission Dates: January 25, 2018; May 25, 2018; January 25, 2019; May 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Limited Competition: Research Resource for Human Organs and Tissues (U42) (RFA-OD-17-001) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date: January 26, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25) (PAR-17-053) National Institute of General Medical Sciences Application Receipt/Submission Dates: January 26, 2018; and January 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25) (PAR-17-040) National Institute of General Medical Sciences Application Receipt/Submission Dates: January 26, 2018; and January 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20) (PAR-16-084) National Cancer Institute Application Receipt/Submission Date: January 29, 2018, by 5:00 PM local time of applicant organization |
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21) (PAR-15-315) National Institute of Neurological Disorders and Stroke National Eye Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Environmental Health Sciences Application Receipt/Submission Date: January 30, 2018, by 5:00 PM local time of applicant organization. |
Summer Research Experiences for Students and Science Teachers (Admin Supp) (PA-17-055) National Institute of Environmental Health Sciences Application Receipt/Submission Dates: January 31, 2018, and January 31, 2019 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33) (PAR-17-162) |
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3) (PAR-17-175) |
Cancer-related Behavioral Research through Integrating Existing Data (R01) (PAR-16-256) National Cancer Institute Application Receipt/Submission Dates: February 7, 2018; June 7 2018; February 7, 2019; June 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01) (PAR-17-206) |
Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (U24) (PAR-17-173) |
NHLBI Early Investigator Award (EIA) (R35) (RFA-HL-16-025) National Heart, Lung, and Blood Institute Application Receipt Date: February 15, 2018, by 5:00 PM local time of applicant organization |
NHLBI Outstanding Investigator Award (OIA) (R35) (RFA-HL-16-024) National Heart, Lung, and Blood Institute Application Receipt Date: February 15, 2018, by 5:00 PM local time of applicant organization |
CVM Vet-LIRN Veterinary Diagnostic Laboratory Program (U18) (PAR-17-141) |
Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21) (PAR-17-004) National Heart, Lung, and Blood Institute Application Receipt/Submission Dates: February 23, 2018; February 22, 2019, by 5:00 PM local time of application organization |
NLM Grants for Scholarly Works in Biomedicine and Health (G13) (PAR-16-417) National Library of Medicine Application Receipt/Submission Date: February 23, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Outstanding New Environmental Scientist (ONES) Award (R01) (RFA-ES-15-020) National Institute of Environmental Health Sciences Application Receipt Date: February 27, 2018, by 5:00 PM local time of applicant organization |
NIH Revision Awards for Creating Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER)(R01) (RFA-ES-17-002) National Institute of Environmental Health Sciences Application Receipt Date: March 6, 2018; March 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
International Research Scientist Development Award (IRSDA) (K01) (PAR-17-002) John E. Fogarty International Center National Cancer Institute Application Receipt/Submission Dates: March 7, 2018; March 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
International Research Scientist Development Award (IRSDA) (K01) (PAR-15-291) John E. Fogarty International Center Application Receipt/Submission Date: March 7, 2018 by 5:00 PM local time of applicant organization. |
Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19) (PAR-15-330) National Institute of Allergy and Infectious Diseases Application Receipt/Submission Dates: March 9, 2018, by 5:00 PM local time of applicant organization. |
Planning for Non-Communicable Diseases and Disorders Research Training Programs in Low and Middle Income Countries (D71) (PAR-17-097) |
Phylodynamic Tracking of HIV Transmission (R01) (PAR-17-048) National Institute of Allergy and Infectious Diseases National Institute on Drug Abuse National Institute of Mental Health Application Receipt/Submission Dates: March 15, 2018; March 15, 2019 , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Data Science Research: Personal Health Libraries for Consumers and Patients (R01) (PAR-17-159) |
Summer Research Education Experience Programs (R25) (PAR-15-184) National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Environmental Health Sciences National Institute of Neurological Disorders and Stroke Application Receipt/Submission Dates: March 23, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 23, 2018, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. |
NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24) (PAR-17-099) |
IDeA Networks of Biomedical Research Excellence (INBRE) (P20) (PAR-17-160) |
NCMRR Early Career Research Award (R03) (PAR-17-161) |
Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01) (PAR-17-163) |
Integrated Food Defense & Emergency Response Cooperative Agreement Program IFD&ER (U18) (RFA-FD-15-022) Food and Drug Administration Office of Foods and Veterinary Medicine/Center for Food Safety and Applied Nutrition Application Receipt Dates: April 2, 2018; April 2, 2019 by 11:59 PM Eastern Time. |
State and Territory Cooperative Agreement to Enhance Produce Safety in Preparation of Implementation of FDA's Rule: Standards for the Growing, Harvesting, Packing, & Holding of Produce for Human Consumption (U18) (PAR-16-137) Food and Drug Administration Office of Foods and Veterinary Medicine/Center for Food Safety and Applied Nutrition Application Receipt/Submission Dates: April 3, 2018, 2019, by 11:59 PM Eastern Time |
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01) (PAR-17-151) |
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21) (PAR-17-150) |
Opportunities for Collaborative Research at the NIH Clinical Center (U01) (PAR-15-287) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Heart, Lung, and Blood Institute National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Neurological Disorders and Stroke Office of Dietary Supplements Office of Research on Women's Health Application Receipt/Submission Dates: April 11, 2018, by 5:00 PM local time of applicant organization |
Environmental Health Sciences Core Centers (EHS CC) (P30) (RFA-ES-17-003) |
Maintenance and Enhancement of ISO/IEC 17025 Accreditation and Whole Genome Sequencing for State Food Testing Laboratories (U18) (RFA-FD-17-010) |
Enhancing Regulatory Science for the Risk Based Assessment of Emerging Manufacturing Technologies (U01) (PAR-15-187) Food and Drug Administration Application Receipt/Submission Dates: April 30, 2018, by 8:00 PM Eastern Time. April 30, 2019, by 8:00 PM Eastern Time. |
Vet-LIRN Cooperative Agreement Program to Develop and Validate Testing Methods for Food Irradiation Specific Markers in Animal Feeds and Treats (U18) (PAR-16-132) Food and Drug Administration Application Receipt/Submission Date: May 01, 2018 |
NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) (PAR-16-099) Food and Drug Administration Application Receipt/Submission Dates: May 1, 2018, 2019, 2020, by 11:59 PM Eastern Time |
Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow Projects (R01) (PAR-16-117) National Institute of Allergy and Infectious Diseases National Institute on Drug Abuse National Institute of Mental Health Application Receipt/Submission Date: May 8, 2018, by 5:00 PM local time of applicant organization |
International Bioethics Research Training Program (D43) (PAR-16-454) John E. Fogarty International Center Application Receipt/Submission Dates: May 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
International Research Ethics Education and Curriculum Development Award (R25) (PAR-16-081) John E. Fogarty International Center National Human Genome Research Institute National Institute of Allergy and Infectious Diseases Application Receipt/Submission Date: May 17, 2018, by 5:00 PM local time of applicant organization |
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50) (PAR-16-354) National Institute of Mental Health Application Receipt/Submission Date: May 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
International Research in Infectious Diseases, including AIDS (R01) (PAR-17-142) |
Maximizing Access to Research Careers Undergraduate - Student Training in Academic Research (MARC U-STAR) (T34) (PAR-17-068) National Institute of General Medical Sciences Application Receipt/Submission Date: May 24, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25) (PAR-17-221) |
NIMH Mentoring Networks for Mental Health Research Education (R25) (PAR-17-080) National Institute of Mental Health Application Receipt/Submission Dates: May 24, 2018; May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
NIMH Research Education Programs for Psychiatry Residents (R25) (PAR-17-081) National Institute of Mental Health Application Receipt/Submission Dates: May 24, 2018; May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
NIMH Short Courses for Mental Health-Related Research Education (R25) (PAR-17-082) National Institute of Mental Health Application Receipt/Submission Dates: May 24, 2018; May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50) (PAR-17-168) |
Maximizing Access to Research Careers Undergraduate - Student Training in Academic Research (MARC U-STAR) (T34) (PAR-16-113) National Institute of General Medical Sciences Application Receipt/Submission Date: May 25, 2018, by 5:00 PM local time of applicant organization |
Research Initiative for Scientific Enhancement (RISE) (R25) (PAR-16-118) National Institute of General Medical Sciences Application Receipt/Submission Date: May 25, 2018, by 5:00 PM local time of applicant organization |
Research Initiative for Scientific Enhancement (RISE) (R25) (PAR-16-361) National Institute of General Medical Sciences Application Receipt/Submission Date: May 25, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
NICHD Research Education Programs (R25) (PAR-17-183) |
Jointly Sponsored Ruth L. Kirschstein National Research Service Award for Institutional Predoctoral Training Programs in the Neurosciences (T32) (PAR-17-096) |
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30) (PAR-17-249) |
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30) (PAR-17-208) |
Team-Based Design in Biomedical Engineering Education (R25) (PAR-16-108) National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt/Submission Date: May 31, 2018, by 5:00 PM local time of applicant organization |
Silvio O. Conte Digestive Diseases Research Core Centers (P30) (RFA-DK-17-001) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date: June 1, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Spermatogenic Stem Cell Culture Systems to Preserve and Restore Reproductive Capacity in Males (R01) (PAR-16-114) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt/Submission Date: June 5, 2018, by 5:00 PM local time of applicant organization |
Methods for Prevention Packages Program IV (MP3 IV) (R01) (PAR-16-124) National Institute of Allergy and Infectious Diseases National Institute of Mental Health Application Receipt/Submission Date: June 7, 2018, by 5:00 PM local time of applicant organization |
Surgical Disparities Research (R01) (PAR-16-391) National Institute on Minority Health and Health Disparities National Cancer Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases Office of Research on Women's Health Application Receipt/Submission Dates: June 7, 2018 and June 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Exploratory/Developmental Surgical Disparities Research (R21) (PAR-16-392) National Institute on Minority Health and Health Disparities National Cancer Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases Office of Research on Women's Health Application Receipt/Submission Dates: June 7, 2018 and June 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |
Limited Competition: Small Grant Program for NIDDK K01/K08/K23 Recipients (R03) (PAR-15-343) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt/Submission Date: September 07, 2018 |
Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25) (PAR-16-139) National Cancer Institute Application Receipt/Submission Date: September 07, 2018 |
Natural History Studies for Rare Disease Product Development: Orphan Products Research Project Grant (R01) (RFA-FD-16-043) Food and Drug Administration Application Receipt Date: October 15, 2018, by 11:59 PM Eastern Time |
BD2K Support for Meetings of Data Science Related Organizations (U13) (RFA-CA-16-020) National Cancer Institute National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Eye Institute National Human Genome Research Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of Nursing Research Office of Behavioral and Social Science Research Office of Research on Women's Health The Common Fund/Office of Strategic Coordination Application Receipt Dates: November 31, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates |
Education and Health: New Frontiers (R21) (PAR-16-078) Office of Behavioral and Social Science Research National Cancer Institute National Institute on Aging Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse Application Receipt/Submission Date: January 07, 2019 |
Education and Health: New Frontiers (R03) (PAR-16-079) Office of Behavioral and Social Science Research National Cancer Institute National Institute on Aging Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse Application Receipt/Submission Date: January 07, 2019 |
Education and Health: New Frontiers (R01) (PAR-16-080) Office of Behavioral and Social Science Research National Cancer Institute National Institute on Aging Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse Application Receipt/Submission Date: January 07, 2019 |
Core Centers for Clinical Research (CCCR) (P30) (RFA-AR-17-002) National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date: January 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates |